Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
All >

News > Collaborations

Find below news about collaborations, licenses, supplies in Europe and Israel or including organisations from these regions.

Total search results: 4846 | Ordered by Date (descending)
1 2 3 ... 47 48 49  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
BioNTech SE. (7/1/20). "Press Release: Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-01
Scienion AG. (6/22/20). "Press Release: Accurate Spike-in of Circulating Tumor Cells into Blood Samples is Essential for Reliable Analysis in Oncology Applications". Berlin, Lyon & Seattle, WA. 2020-06-22
Lead Discovery Center GmbH. (6/18/20). "Pressemitteilung: Neue Forschungsinfrastruktur in Bochum – Center für systembasierte Antibiotikaforschung (CESAR) eröffnet". Dortmund & Bochum. 2020-06-18
eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel. 2020-06-16
Lead Discovery Center GmbH. (6/16/20). "Press Release: LDC and Qurient Launch Start-up QLi5 Therapeutics in Dortmund, Germany". Dortmund. 2020-06-16
GlaxoSmithKline plc. (6/16/20). "Press Release: Ideaya and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology". South San Francisco, CA & London. 2020-06-16
Epsilen Bio S.r.l.. (6/15/20). "Press Release: Epsilen Bio Appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board. Company Announces Strategic Collaboration with SR-Tiget". Milan. 2020-06-15
Bavarian Nordic A/S. (6/12/20). "Press Release: Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen". Copenhagen. 2020-06-12
Egle Therapeutics S.A.S.. (6/11/20). "Press Release: Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies". Pa 2020-06-11
Applied Process Company Ltd. (APC Ltd.). (6/10/20). "Press Release: Irish Company APC Partners with Australian Biotechnology Firm Vaxine to Accelerate the Development and Delivery of New Covid-19 Vaccine candidate". Dublin. 2020-06-10
Merck KGaA. (6/10/20). "Press Release: Merck and 10x Genomics Launch Powerful New Option for CRISPR Research". Darmstadt. 2020-06-10
Genmab A/S. (6/10/20). "Press Release: Genmab and AbbVie Announce Broad Oncology Collaboration". Copenhagen & North Chicago, IL. 2020-06-10
Scienion AG. (6/9/20). "Press Release: Scienion and Randox Expand Collaboration to Transform High Throughput Biochip Manufacturing". Berlin & Crumlin. 2020-06-09
Evox Therapeutics Ltd.. (6/9/20). "Press Release: Evox Therapeutics Announces a Multi-target RNA Interference and Antisense Research Collaboration and License Agreement with Lilly". 2020-06-09
AiCuris Anti-infective Cures GmbH. (6/9/20). "Press Release: Royalty Pharma Acquires Partial Royalty Interest on Prevymis (Letermovir) from AiCuris Anti-infective Cures GmbH". New York, NY & Wuppertal. 2020-06-09
Oxford Biomedica plc. (6/8/20). "Press Release: Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre". Oxford. 2020-06-08
Valo Therapeutics Ltd.. (6/8/20). "Press Release: Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca". Oxford & Helsinki. 2020-06-08
Rigenerand S.r.l.. (6/2/20). "Press Release: Rigenerand Receives Regulatory Approval for Gene Therapy Production". Modena. 2020-06-02
Rentschler Biopharma SE. (5/27/20). "Press Release: Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility". Laupheim & Milford, MA. 2020-05-27
Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ. 2020-05-26
GlaxoSmithKline plc. (5/21/20). "Press Release: GSK Partners with Samsung Biologics to Secure Additional Manufacturing Capacity for Innovative Biopharmaceutical Portfolio". London & Songdo. 2020-05-21
Rentschler Biopharma SE. (5/19/20). "Press Release: Rentschler Biopharma Licenses Horizon Discovery's CHOSource Platform to Complement Cell Line Development Offering for Difficult-to-Express Proteins". Laupheim, Milford, MA & Cambridge. 2020-05-19
Syngulon S.A.. (5/16/20). "Press Release: Enzymicals and Syngulon Sign a Non-exclusive License Agreement on the Use of Syngulon’s Antibiotic Free Technology to Produce Enzymes". Seraing. 2020-05-16
Lava Therapeutics B.V.. (5/15/20). "Press Release: Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics". Utrecht. 2020-05-15
BaseLaunch (BaselArea.swiss). (5/15/20). "Press Release: Roche Becomes Founding Partner of BaseLaunch Phase II". Basel. 2020-05-15
Immunai. (5/14/20). "Press Release: Immunai Launches to Fully Map the Entire Immune System to Better Develop Immunotherapies and Cell Therapies". New York, NY. 2020-05-14
CellGenix GmbH. (5/13/20). "Press Release: Ori Biotech and CellGenix to Collaborate in Order to Promote Innovation within Closed-system, Cell and Gene Therapy Manufacturing". Freiburg & London. 2020-05-13
Optibrium Ltd.. (5/12/20). "Press Release: Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific". Cambridge & Santa Fe, NM. 2020-05-12
Idorsia Ltd.. (5/12/20). "Press Release: Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy". San Diego, CA & Allschwil. 2020-05-12
Apceth Biopharma GmbH. (5/11/20). "Press Release: Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with bluebird bio". Allendale, NJ & Munich. 2020-05-11
CRISPR Therapeutics AG. (5/11/20). "Press Release: CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001 for the Treatment of Severe Hemoglobinopathies". Zug, Cambridge, MA 2020-05-11
Dyno Therapeutics, Inc.. (5/11/20). "Press Release: Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology". Cambridge, MA. 2020-05-11
Yumab GmbH. (5/7/20). "Press Release: Yumab Identifies Promising Candidate for Covid-19 Antibody Therapy". Braunschweig. 2020-05-07
Dentons. (5/5/20). "Press Release: Dentons Advises Biotech Company Pluristem on European Investment Bank Financing". Düsseldorf & Frankfurt a. M.. 2020-05-05
Exscientia Ltd.. (5/5/20). "Press Release: SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence". Menlo Park, CA & Oxford. 2020-05-05
BioNTech SE. (5/5/20). "Press Release: Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program". New York, NY & Mainz. 2020-05-05
Transgene S.A.. (5/4/20). "Press Release: Vaxxel Acquires Transgene’s DuckCelt-T17 Cell Line to Develop Industrial-scale Vaccines against Respiratory Viruses". Lyon & Strasbourg. 2020-05-04
Lonza Ltd.. (5/1/20). "Press Release: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) against Novel Coronavirus". Cambridge, MA & Basel. 2020-05-01
Valneva S.E.. (4/30/20). "Press Release: Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15". Saint-Herblain & New York, NY. 2020-04-30
Evotec SE. (4/30/20). "Press Release: Just – Evotec Biologics to Collaborate with Ology Bioservices on Antibodies against Coronavirus". Hamburg. 2020-04-30
BioNTech SE. (4/29/20). "Press Release: BioNTech and Pfizer Announce Completion of Dosing for First Cohort of Phase 1/2 Trial of COVID-19 Vaccine Candidates in Germany". Mainz & New York, NY. 2020-04-29
Robocath S.A.S.. (4/29/20). "Press Release: Robocath Secures €40 Million Series C Financing Round to Deploy Its Operations Development Plan". Rouen. 2020-04-29
Genedata AG. (4/28/20). "Press Release: Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection". Basel. 2020-04-28
Biognosys AG. (4/28/20). "Press Release: Gustave Roussy and Biognosys Announce Partnership". Schlieren & Villejuif. 2020-04-28
Valneva S.E.. (4/22/20). "Press Release: Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19". Saint-Herblain & Emeryville, CA. 2020-04-22
Evotec SE. (4/22/20). "Press Release: Evotec Regains Global Rights to Beta Cell Replacement Therapy". Hamburg. 2020-04-22
BioNTech SE. (4/22/20). "Press Release: BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates". Mainz & New York, NY. 2020-04-22
Cell Mogrify Ltd.. (4/21/20). "Press Release: Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-derived Regulatory T Cells". Cambridge & Brisbane, CA. 2020-04-21
Centogene B.V.. (4/17/20). "Press Release: Centogene and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19". Rostock & Cologne. 2020-04-17
Cevec Pharmaceuticals GmbH. (4/16/20). "Press Release: Cevec Signs License Agreement for the Development and Commercialization of Exosomes for Therapeutic Use". Cologne. 2020-04-16
Galapagos N.V.. (4/16/20). "Press Release: Galapagos and Ryvu Announce Research Collaboration". Mechelen & Krakow. 2020-04-16
Evotec SE. (4/16/20). "Press Release: Evotec Enters Nanomedicine through Strategic Partnership with Leon-Nanodrugs". Hamburg. 2020-04-16
Leo Pharma A/S. (4/15/20). "Press Release: Leo Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate". Ballerup. 2020-04-15
LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. 2020-04-15
GlaxoSmithKline plc. (4/14/20). "Press Release: Sanofi and GSK to Join Forces in Unprecedented Vaccine Collaboration to Fight COVID-19". London. 2020-04-14
BioNTech SE. (4/9/20). "Press Release: Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development". Mainz & New York, NY. 2020-04-09
Arrakis Therapeutics, Inc.. (4/8/20). "Press Release: Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform". Waltham, MA. 2020-04-08
Sirion Biotech GmbH. (4/7/20). "Press Release: Beam Therapeutics Licenses Sirion Biotech’s LentiBOOST Technology for Its CAR-T pipeline". Martinsried. 2020-04-07
Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. 2020-04-06
GlaxoSmithKline plc. (4/6/20). "Press Release: GSK and Vir Biotechnology Enter Collaboration to Find Coronavirus Solutions". London & San Francisco, CA. 2020-04-06
ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. 2020-04-02
Evotec SE. (4/2/20). "Press Release: Evotec Expands Its iPSC-based Cell Therapy Platform Evocells through Licensing Agreement with PanCella". Hamburg & Toronto. 2020-04-02
Neurimmune AG. (4/1/20). "Press Release: Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of Covid-19". Zurich & Munich. 2020-04-01
Sitryx Therapeutics Ltd.. (3/31/20). "Press Release: Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines". Indianapolis, IN & Oxford. 2020-03-31
Evotec SE. (3/31/20). "Press Release: Evotec and Ildong to Collaborate with Development Projects on INDiGO Platform". Hamburg. 2020-03-31
Exscientia Ltd.. (3/31/20). "Press Release: Exscientia Announces Joint Initiative to Identify COVID-19 Drugs with Diamond Light Source and Scripps Research". 2020-03-31
Numab Therapeutics AG. (3/30/20). "Press Release: Numab Therapeutics Expands Immuno-Oncology Research Alliance with Ono Pharmaceutical Co., Ltd.". Wädenswil (Zurich). 2020-03-30
ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA. 2020-03-30
Sophia Genetics S.A.. (3/26/20). "Press Release: Sophia Genetics and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic". Lausanne & Boston, MA. 2020-03-26
Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration". 2020-03-26
Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". 2020-03-26
Debiopharm International SA. (3/25/20). "Press Release: Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-licensing Agreement of 3B Pharmaceutical’s Targeted CAIX Radiotherapy". Lausanne. 2020-03-25
Forge Therapeutics, Inc.. (3/25/20). "Press Release: Forge Enters into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections". San Diego, CA. 2020-03-25
Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London. 2020-03-25
Proteona Pte. Ltd.. (25/3/20). "Press Release: Proteona Leads International Consortium to Develop SARS-CoV-2 Neutralizing Antibody to Help Vulnerable Immunocompromised Individuals". Singapore. 2020-03-25
Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London. 2020-03-25
Evotec SE. (3/25/20). "Press Release: Evotec Partner Forge Enters into Collaboration with Roche to Develop Novel Antibiotic". San Diego, CA. 2020-03-25
ProBioGen AG. (3/24/20). "Press Release: Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Houston, TX. 2020-03-24
Genedata AG. (3/23/20). "Press Release: CytomX Therapeutics Deploys Genedata Bioprocess". South San Francisco, CA & Tokyo. 2020-03-23
AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. 2020-03-23
Roche. (3/23/20). "Press Release: Roche Announces Venclexta/Venclyxto Combination Improved Overall Survival in People with Previously Untreated Acute Myeloid Leukaemia". Basel. 2020-03-23
Proteona Pte. Ltd.. (23/3/20). "Press Release: One More Step towards True Precision Medicine. Proteona, Synovo, and NMI Announced Collaboration on a Single Cell Multi-omics Profiling Platform for Patient-derived Micro-tumors". Singapore. 2020-03-23
Bayer AG. (23/3/20). "Press Release: Bayer and Curadev Sign Research Collaboration and License Agreement to Develop Novel STING Antagonists across Indications". Berlin & New Delhi. 2020-03-23
Oxford Biomedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. 2020-03-18
BioNTech SE. (3/17/20). "Press Release: Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine". New York, NY & Mainz. 2020-03-17
BioNTech SE. (3/16/20). "Press Release: BioNTech and Fosun Pharma Form COVID-19 Vaccine Strategic Alliance in China". Mainz & Shanghai. 2020-03-16
CureVac AG. (3/15/20). "Press Release: CureVac Focuses on the Development of mRNA-based Coronavirus Vaccine to Protect People Worldwide. The Company Rejects Current Rumors of an Acquisition". Tübingen & Boston, MA. 2020-03-15
Genedata AG. (3/10/20). "Press Release: Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery". Tokyo. 2020-03-10
Calixar S.A.S.. (3/9/20). "Press Release: Calixar Launches New Funding Round to Establish Business Strategy". Lyon. 2020-03-09
MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. 2020-03-06
Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. 2020-03-05
Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen. 2020-03-05
Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen. 2020-03-05
Voluntis S.A.. (3/3/20). "Press Release: Voluntis and Bristol-Myers Squibb to Co-develop Digital Therapeutics for Oncology". New York, NY & Paris. 2020-03-03
Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton. 2020-03-03
Agilent Technologies Inc.. (3/2/20). "Press Release: Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions". Santa Clara, CA & Copenhagen. 2020-03-02
Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Advanced Liquid Chromatography System Delivers Productivity, Precision and Compliance in Routine Analyses". Germering. 2020-03-02
Uniqure N.V.. (3/2/20). "Press Release: Uniqure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters". Lexington, MA & Amsterdam. 2020-03-02
MorphoSys AG. (3/2/20). "Press Release: FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory DLBCL". Planegg. 2020-03-02
Evonetix Ltd.. (3/2/20). "Press Release: Evonetix Raises $30 Million USD (£23 Million GBP)". Cambridge. 2020-03-02
1 2 3 ... 47 48 49  next pagenext page



Advertisement

Picture [iito] Männer Ballett 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top